Advances in multiple myeloma treatment over the last years
Are complex karyotypes reliable prognostic markers for CLL?
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.
How can patients be advised about working with medical conditions?
Cytokines and their impact on the severity of myelofibrosis
Ruben A. Mesa